XML 41 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements, Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Jun. 30, 2015
Fair Value Measurements [Abstract]      
Transfers from Level 1 to Level 2 $ 0    
Transfers from Level 2 to Level 1 0    
Fair Value Measurements [Abstract]      
Available-for-sale securities 595,916 $ 682,728  
Investment in Regulus Therapeutics Inc. $ 8,217 $ 24,792  
1 Percent Convertible Senior Notes [Member]      
Fair Value Measurements [Abstract]      
Interest rate on convertible senior notes 1.00% 1.00% 1.00%
Fair value of convertible notes $ 350,600    
2 3/4 Percent Convertible Senior Notes [Member]      
Fair Value Measurements [Abstract]      
Interest rate on convertible senior notes 2.75% 2.75% 2.75%
Fair value of convertible notes $ 89,800    
Recurring Basis [Member]      
Fair Value Measurements [Abstract]      
Cash equivalents [1] 68,737 $ 88,902  
Investment in Regulus Therapeutics Inc. 8,217 24,792  
Total assets 664,653 771,630  
Recurring Basis [Member] | Corporate Debt Securities [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities [2] 371,197 438,426  
Recurring Basis [Member] | Corporate Debt Securities [Member] | Cash and Cash Equivalents [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 16,000    
Recurring Basis [Member] | Debt Securities issued by U.S. Government Agencies [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 76,734 [3] 89,253 [2]  
Recurring Basis [Member] | Debt Securities issued by the U.S. Treasury [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities [2] 22,071 2,601  
Recurring Basis [Member] | Debt Securities issued by States of the U.S. and Political Subdivisions of the States [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities [4] 117,697 127,656  
Recurring Basis [Member] | Debt Securities issued by States of the U.S. and Political Subdivisions of the States [Member] | Cash and Cash Equivalents [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 20,100 7,500  
Recurring Basis [Member] | Quoted Prices in Active Markets (Level 1) [Member]      
Fair Value Measurements [Abstract]      
Cash equivalents 68,737 88,902  
Investment in Regulus Therapeutics Inc. 8,217 24,792  
Total assets 99,025 116,295  
Recurring Basis [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Corporate Debt Securities [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 0 0  
Recurring Basis [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Debt Securities issued by U.S. Government Agencies [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 0 0  
Recurring Basis [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Debt Securities issued by the U.S. Treasury [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 22,071 2,601  
Recurring Basis [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Debt Securities issued by States of the U.S. and Political Subdivisions of the States [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 0 0  
Recurring Basis [Member] | Significant Other Observable Inputs (Level 2) [Member]      
Fair Value Measurements [Abstract]      
Cash equivalents 0 0  
Investment in Regulus Therapeutics Inc. 0 0  
Total assets 565,628 655,335  
Recurring Basis [Member] | Significant Other Observable Inputs (Level 2) [Member] | Corporate Debt Securities [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 371,197 438,426  
Recurring Basis [Member] | Significant Other Observable Inputs (Level 2) [Member] | Debt Securities issued by U.S. Government Agencies [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 76,734 89,253  
Recurring Basis [Member] | Significant Other Observable Inputs (Level 2) [Member] | Debt Securities issued by the U.S. Treasury [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities 0 0  
Recurring Basis [Member] | Significant Other Observable Inputs (Level 2) [Member] | Debt Securities issued by States of the U.S. and Political Subdivisions of the States [Member]      
Fair Value Measurements [Abstract]      
Available-for-sale securities $ 117,697 $ 127,656  
[1] Included in cash and cash equivalents on our condensed consolidated balance sheet.
[2] Included in short-term investments on our condensed consolidated balance sheet.
[3] At June 30, 2016, $16.0 million was included in cash and cash equivalents on our condensed consolidated balance sheet, with the difference included in short-term investments on our condensed consolidated balance sheet.
[4] At June 30, 2016 and December 31, 2015, $20.1 million and $7.5 million, respectively, were included in cash and cash equivalents on our condensed consolidated balance sheet, with the difference included in short-term investments on our condensed consolidated balance sheet.